Mirae Asset Securities (Usa) Inc. Crispr Therapeutics Ag Transaction History
Mirae Asset Securities (Usa) Inc.
- $2.11 Trillion
- Q2 2024
A detailed history of Mirae Asset Securities (Usa) Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Mirae Asset Securities (Usa) Inc. holds 7,534 shares of CRSP stock, worth $372,857. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,534Holding current value
$372,857% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding CRSP
# of Institutions
523Shares Held
58MCall Options Held
1.73MPut Options Held
1.84M-
Capital International Investors Los Angeles, CA7.87MShares$389 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.78MShares$385 Million3.82% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$156 Million0.13% of portfolio
-
Nikko Asset Management Americas, Inc.3.15MShares$156 Million1.99% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$137 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.86B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....